BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12946833)

  • 1. The genetics of pancreatic cancer.
    Cowgill SM; Muscarella P
    Am J Surg; 2003 Sep; 186(3):279-86. PubMed ID: 12946833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathobiology of pancreatic adenocarcinoma.
    Mangray S; King TC
    Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreas in Hereditary Syndromes: Cross-sectional Imaging Spectrum.
    Katabathina VS; Buddha S; Rajebi H; Shah JN; Morani AC; Lubner MG; Dasyam A; Nazarullah A; Menias CO; Prasad SR
    Radiographics; 2021; 41(4):1082-1102. PubMed ID: 34143711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Syndromes with Pancreatic Manifestations.
    Pittman ME; Brosens LA; Wood LD
    Surg Pathol Clin; 2016 Dec; 9(4):705-715. PubMed ID: 27926368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary gastric and pancreatic cancer predisposition syndromes].
    Leoz ML; Sánchez A; Carballal S; Ruano L; Ocaña T; Pellisé M; Castells A; Balaguer F; Moreira L
    Gastroenterol Hepatol; 2016; 39(7):481-93. PubMed ID: 26916701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of pancreatic cancer.
    Hilgers W; Rosty C; Hahn SA
    Hematol Oncol Clin North Am; 2002 Feb; 16(1):17-35, v. PubMed ID: 12063826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic adenocarcinoma: epidemiology and genetics.
    Flanders TY; Foulkes WD
    J Med Genet; 1996 Nov; 33(11):889-98. PubMed ID: 8950667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in cancer genetics: lessons from pancreatic cancer.
    Goggins M; Kern SE; Offerhaus JA; Hruban RH
    Ann Oncol; 1999; 10 Suppl 4():4-8. PubMed ID: 10436774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Management of Hereditary Pancreatic Cancer.
    Humphris JL; Biankin AV
    Recent Results Cancer Res; 2016; 205():61-83. PubMed ID: 27075349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a major gene influencing risk of pancreatic cancer.
    Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
    Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.
    Hahn SA; Schmiegel WH
    Digestion; 1998 Aug; 59(5):493-501. PubMed ID: 9705534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
    Noë M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
    Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic pancreas surgery].
    Langer P; Rothmund M; Bartsch DK
    Chirurg; 2006 Jan; 77(1):25-32. PubMed ID: 16307289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
    Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
    Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
    DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
    Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.